Category: News

Appier Recognized as an IDC Innovator for Asia-Pacific Data-as-a-Service Provider 2018

SINGAPORE – Media OutReach – March 27, 2018 – Appier, a leading artificial intelligence (AI) company, has been named by International Data Corporation (IDC)

AR startup Magic Leap raises USD461 million from Saudi Arabia fund

(Reuters) – Magic Leap, a secretive startup working in the augmented reality space, said on Wednesday it raised $461 million in its latest funding

Tessa Therapeutics – Bright sparks in the biomedical sector

Singapore-based biotechnology firm Tessa Therapeutics (Tessa) has come a long way from the Singapore cafe where the idea of its inception was hatched.

PEAR Therapeutics to Collaborate with Novartis to Develop Prescription Digital Therapeutics

BOSTON, and SAN FRANCISCO, March 1, 2018—PEAR Therapeutics announced today that it has entered into a collaboration with Novartis to develop novel prescription digital

Joby Aviation Secures USD100M in Series B Funding to Make Electric Vertical Take-off and Landing Transportation a Reality

SANTA CRUZ, Calif. – February 1, 2018 – Joby Aviation announced it has secured $100M in Series B financing to take its all-electric vertical

Moderna Closes USD500 Million Equity Financing

CAMBRIDGE, Mass., February 1, 2018 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create

Engine Biosciences Raises USD10 Million in Largest Institutional Seed Financing Seen in South East Asia

Singapore and San Francisco-based biotech company raises US$10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua

Yang Kee Logistics completes SGD52.1m acquisition of New Zealand peer Fliway

YANG Kee Logistics on Thursday said it has completed the acquisition of New Zealand listed company, Fliway Group, for S$52.1 million – making it

EDBI Participates in PEAR Therapeutics’ USD50 Million Series B Financing Round

BOSTON, and SAN FRANCISCO, January 2, 2018– PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50

EDBI participates in Tessa Therapeutics’ USD 80 Million Financing Round

SINGAPORE – 20 December 2017 – Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, today announced